2seventy bio

About:

2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.

Website: https://www.2seventybio.com

Top Investors: Regeneron, RTW Investments, Casdin Capital, Bain Capital Life Sciences, Janus Henderson Investors

Description:

22seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies. The company combines a deep knowledge of cancer cell biology and genetics with an understanding of the immune response to cancer to advance its pipeline. It was established in Cambridge, Massachusetts in 2021.

Total Funding Amount:

$315M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2021-01-01

Contact Email:

info(AT)2seventybio.com

Founders:

Number of Employees: